HOT AIR BALLOON FLIGHT

The panel endorsed a half-dose as a third injection for people 65 and older as well as younger adults at high risk because of their medical conditions or jobs, the same groups of people who became eligible for a Pfizer-BioNTech booster last month.

While regulators are not obligated to follow the panel's recommendations, they typically do.